Skip to content

EBITDA at other companies

Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
-$14.85M-50.0%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
-$43.57M-36.3%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$20.88M-43.7%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-$14.65M-8.9%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$82.36M-31.0%
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Revenue$2.0M+37.2%
Gross profit$1.6M+68.7%
Operating income-$22.2M-22.7%
Net income-$19.8M-31.4%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$28.7M-5.6%
Total debt$2.0M-20.1%
Total equity$143.6M-0.3%
Total assets$198.7M+0.3%

Cash flow

See full
Operating cash flow-$18.1M-39.0%
CapEx$13.0K-69.8%
Free cash flow-$18.2M-38.6%

Valuation

See full
Market cap$685.75M+337%
Enterprise value$659.07M+410%
P/S82×+73.1×

Profitability

See full
Gross margin76.3%-9.7pp
Operating margin-961.9%+259pp
Net margin-832.6%+132pp
FCF margin-624.9%

Returns & leverage

See full
Return on equity-48.4%-15.4pp
Debt / equity0.0×
Current ratio-1.0×

Where this comes from

Calculated from Aclaris Therapeutics’s reported figures.

$22.2Mebit+
$102.0KDepreciation Depletion & Amortization
=-$22.09M

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aclaris Therapeutics's EBITDA?
Aclaris Therapeutics (ACRS) reported EBITDA of -$22.09M in Q1 2026.
How has Aclaris Therapeutics's EBITDA changed year-over-year?
Aclaris Therapeutics's EBITDA decreased by 23.0% year-over-year, from -$17.96M to -$22.09M.
What is the long-term trend for Aclaris Therapeutics's EBITDA?
Over 4 years (2021 to 2025), Aclaris Therapeutics's EBITDA has grown at a -3.8% compound annual growth rate (CAGR), from -$88.8M to -$75.92M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.